Literature DB >> 15473410

Ovarian cancer: the neglected diagnosis.

Barbara P Yawn1, Brigitte A Barrette, Peter C Wollan.   

Abstract

OBJECTIVE: To investigate presenting signs and symptoms of ovarian cancer and stage of tumor in a community cohort of women with the diagnosis of ovarian cancer. PATIENTS AND METHODS: We reviewed retrospectively the medical records of all women who sought primary and specialty care in Olmsted County, Minnesota, between January 1, 1985, and December 31, 1997, to evaluate presenting symptoms, time from first symptom to diagnosis of ovarian cancer, and stage of tumor at diagnosis.
RESULTS: Of 107 women with a diagnosis of ovarian cancer, the most commonly documented presenting symptom was crampy abdominal pain. Urinary symptoms and abdominal pain were the most commonly documented presenting symptom in patients with stage I and II ovarian cancers, whereas abdominal pain and increased abdominal girth were the most commonly documented symptoms in patients with stage III and IV cancer. Approximately 15% of tumors (n = 15) were found during routine evaluations or during a procedure for another problem. Less than 25% of presenting symptoms (n = 24 women) related directly to the pelvis or were more traditional gynecologic symptoms. Delays in women seeking medical care, health care system issues, competing medical conditions, physicians' failure to follow up, and women not returning for follow-up were associated with longer time to diagnosis.
CONCLUSION: Both stage I and II cancer are associated with symptoms, but few symptoms are directly related to the reproductive pelvic organs or unique to ovarian cancer. A longer interval from first sign or symptom to diagnosis of ovarian cancer is associated with both patient and health care system factors.

Entities:  

Mesh:

Year:  2004        PMID: 15473410     DOI: 10.4065/79.10.1277

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

1.  Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability.

Authors:  Barbara A Goff; Kimberly A Lowe; Jeannette C Kane; Marissa D Robertson; Marcia A Gaul; M Robyn Andersen
Journal:  Gynecol Oncol       Date:  2011-11-06       Impact factor: 5.482

2.  Determining the date of diagnosis--is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary care.

Authors:  A Rosemary Tate; Alexander G R Martin; Tarita Murray-Thomas; Sarah R Anderson; Jackie A Cassell
Journal:  BMC Med Res Methodol       Date:  2009-06-23       Impact factor: 4.615

Review 3.  Genomic analysis of epithelial ovarian cancer.

Authors:  John Farley; Laurent L Ozbun; Michael J Birrer
Journal:  Cell Res       Date:  2008-05       Impact factor: 25.617

4.  A hospital-based case-control study of identifying ovarian cancer using symptom index.

Authors:  Mi-Kyung Kim; Kidong Kim; Sun Min Kim; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

5.  Prediagnostic symptoms of ovarian carcinoma: a case-control study.

Authors:  Galina Lurie; Pamela J Thompson; Katharine E McDuffie; Michael E Carney; Marc T Goodman
Journal:  Gynecol Oncol       Date:  2009-05-22       Impact factor: 5.482

6.  Intention to seek care for symptoms associated with gynecologic cancers, HealthStyles survey, 2008.

Authors:  Katrina F Trivers; Juan L Rodriguez; Nikki A Hawkins; Crystale Purvis Cooper; Lindsey Polonec; Cynthia A Gelb
Journal:  Prev Chronic Dis       Date:  2011-10-17       Impact factor: 2.830

Review 7.  Targeting Aquaporins in Novel Therapies for Male and Female Breast and Reproductive Cancers.

Authors:  Sidra Khan; Carmela Ricciardelli; Andrea J Yool
Journal:  Cells       Date:  2021-01-22       Impact factor: 6.600

8.  Estimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical records.

Authors:  Anita WeyWey Lim; David Mesher; Peter Sasieni
Journal:  BMC Fam Pract       Date:  2014-12-12       Impact factor: 2.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.